Royal Brompton & Harefield NHS Foundation Trust: Idiopathic Pulmonary Fibrosis trials

The registry lists 11 Idiopathic Pulmonary Fibrosis studies with Royal Brompton & Harefield NHS Foundation Trust as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 1Phase 3 1Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic MedicationsRecruitingNCT07332117
• Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis CoughCompletedNCT04429516Phase 3Results posted
• Reliability and Validity of iOS in IPFCompletedNCT04572971
• Changes in iOS in IPFActive, not recruitingNCT04572958
• Muscle Stimulation in Advanced Idiopathic Pulmonary FibrosisCompletedNCT03499275Not applicable
• Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary FibrosisCompletedNCT02530736
• Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary FibrosisCompletedNCT02445157
• The Predictive Ability of 4MGS in IPFCompletedNCT02436278
• IPF Drug Deposition StudyCompletedNCT01457261Phase 1
• Prospective Observation of Fibrosis in the Lung Clinical Endpoints StudyCompletedNCT01110694
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyStatus unknownNCT00637065Phase 4